Namrata S Patil

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Venues

Nature

The Journal of pathology

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiao Li, Jeffrey Eastham, Jennifer M Giltnane, Wei Zou, Andries Zijlstra, Evgeniy Tabatsky, Romain Banchereau, Ching-Wei Chang, Barzin Y Nabet, Namrata S Patil, Luciana L Molinero, Steve Chui, Maureen Harryman, Shari Lau, Linda Rangell, Yannick Waumans, Mark M Kockx, Darya Orlova, Hartmut Koeppen
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy. The Journal of pathology (2024)
Xiao Li, Jeffrey Eastham, Jennifer M Giltnane, Wei Zou, Andries Zijlstra, Evgeniy Tabatsky, Romain Banchereau, Ching-Wei Chang, Barzin Y Nabet, Namrata S Patil, Luciana L Molinero, Steve Chui, Maureen Harryman, Shari Lau, Linda Rangell, Yannick Waumans, Mark M Kockx, Darya Orlova, Hartmut Koeppen
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy. The Journal of pathology 263 (2) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiao Li, Jeffrey Eastham, Jennifer M Giltnane, Wei Zou, Andries Zijlstra, Evgeniy Tabatsky, Romain Banchereau, Ching-Wei Chang, Barzin Y Nabet, Namrata S Patil, Luciana L Molinero, Steve Chui, Maureen Harryman, Shari Lau, Linda Rangell, Yannick Waumans, Mark M Kockx, Darya Orlova, Hartmut Koeppen
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy. The Journal of pathology 263 (2) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiao Li, Jeffrey Eastham, Jennifer M Giltnane, Wei Zou, Andries Zijlstra, Evgeniy Tabatsky, Romain Banchereau, Ching-Wei Chang, Barzin Y Nabet, Namrata S Patil, Luciana L Molinero, Steve Chui, Maureen Harryman, Shari Lau, Linda Rangell, Yannick Waumans, Mark M Kockx, Darya Orlova, Hartmut Koeppen
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy. The Journal of pathology 263 (2) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis Dunkle, Patrick S Chang, Chia-Jung Han, Stephanie Mittman, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Lynne Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Sanjeev Mariathasan, David S Shames, Raymond Meng, Eugene Y Chiang, Robert J Johnston, Namrata S Patil
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells. Nature 627 (8004) (2024)
Charles M Rudin, Stephen V Liu, Ross Andrew Soo, Shun Lu, Min Hee Hong, Jong-Seok Lee, Maciej Bryl, Daphne W Dumoulin, Achim Rittmeyer, Chao-Hua Chiu, Ozgur Ozyilkan, Melissa Lynne Johnson, Alejandro Navarro, Silvia Novello, Yuichi Ozawa, Sammi Hiu Tam, Namrata S Patil, Xiaohui Wen, Meilin Huang, Tien Hoang, Raymond Meng, Martin Reck
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Wei Zou, Stephanie J Yaung, Frederike Fuhlbrück, Marcus Ballinger, Eric Peters, John F Palma, David S Shames, David R Gandara, Yuqiu Jiang, Namrata S Patil
ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy. JCO precision oncology 5 (2022)
Namrata S Patil, Wei Zou, Simonetta Mocci, Alan Sandler, Marcus Ballinger, Susan Flynn, Marcin Kowanetz, Priti S Hegde
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients. PloS one 16 (2) (2021)

Namrata S Patil.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Namrata S Patil